Home / Inspections / 1256057

FDA Inspection 1256057 — Harborview Medical Center

Harborview Medical Center — FEI 3000281640

The FDA completed an inspection of Harborview Medical Center on October 28, 2024 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 28, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Seattle, WA (United States)

Facility

Other inspections at this facility

  • 1167127 (NAI Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1024415 (NAI Mon Aug 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 900844 (NAI Thu Oct 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 874438 (NAI Tue Apr 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 734391 (VAI Fri Jul 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources